Page last updated: 2024-09-03

ulipristal acetate and Fibroid

ulipristal acetate has been researched along with Fibroid in 184 studies

Research

Studies (184)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	136 (73.91)	24.3611
2020's	48 (26.09)	2.80

Authors

Authors	Studies
Guo, H; Ha, R; Hibshoosh, H; Pike, MC; Polaneczky, M; Wang, Z; Westhoff, CL	1
Bet, PM; Clark, TJ; de Lange, ME; Hehenkamp, WJK; Huirne, JAF; Middelkoop, MA; Mol, BWJ	1
Cosyns, S; Dony, N; Polyzos, NP; Tournaye, H	1
Aaltonen, LA; Bützow, R; Heikinheimo, O; Ilves, ST; Kaasinen, E; Karhu, A; Kaukomaa, J; Kolterud, Å; Kopp Kallner, H; Kuisma, H; Mäkinen, N; Palin, K; Pasanen, A; Patomo, J; Välimäki, N	1
Arzoo, S; Ferdous, NE; Khatun, R; Mahmood, S; Rahman, R; Tanzin, F; Yousuf, S	1
Choi, J; Kim, HG; Kyeong, HK; Na, YJ	1
Cho, YJ; Choi, JJ; Choi, JY; Hwang, JR; Kim, HS; Lee, JW; Ryu, JY; Sa, JK	1
Angioni, S; Castellacci, E; Di Spiezio Sardo, A; Franchini, M; Giarrè, G; Malune, ME; Saccone, G	1
Bongers, MY; de Milliano, I; Hehenkamp, WJK; Huirne, JAF; Radder, C; Thurkow, AL; van de Lande, J; van de Ven, PM; van Vliet, H	1
Cosyns, S; De Vree, B; Donnez, O; Godin, PA; Luyckx, M; Nisolle, M; Verguts, J	1
Allaire, C; Laberge, PY; Leyland, N; Murji, A; Singh, SS; Vilos, GA	1
Agostini, A; Netter, A; Pauly, V; Pivano, A; Siles, P; Vidal, V	1
Arena, A; Degli Esposti, E; Del Forno, S; Iodice, R; Leonardi, D; Paradisi, R; Raimondo, D; Salucci, P; Seracchioli, R	1
Al-Hendy, A; Anam, A; Burman, A; Flannery, C; Kisanga, EP; Millard, CEF; Small, B; Whirledge, S	1
De Milliano, I; Frijlingh, M; Hehenkamp, WJK; Huirne, JAF	1
Acosta, K; Binkley, P; Dileep, KV; Nair, HB; Nickisch, K; Santhamma, B; Schenken, R; Zhang, KYJ	1
Cirillo, F; Levi-Setti, PE; Patrizio, P	1
Ciarmela, P; Del Bello, B; Luisi, S; Maellaro, E; Marcolongo, P; Petraglia, F; Sorbi, F	1
Benedetti Panici, P; Del Negro, V; Di Donato, V; Fischetti, M; Fracassi, A; Muzii, L; Palaia, I; Schiavi, M	1
Barra, F; Cianci, A; Ferrero, S; Paudice, M; Scala, C; Vellone, VG; Vitale, SG	1
Capmas, P; Fernandez, H; Laberge, P; Pourcelot, AG	1
Kosmas, IP; Malvasi, A; Mynbaev, OA; Sparic, R; Tinelli, A; Vergara, D	1
Aly, JM; Britten, J; Catherino, WH; Malik, M; Parikh, TP; Pilgrim, J	1
Barra, F; Caruso, S; Cianci, A; Ciebiera, M; Ferrero, S; Marín-Buck, A; Török, P; Vilos, GA; Vitagliano, A; Vitale, SG	1
Delay, JM; Dominique, HB; Herrero, A; Meszaros, M; Meunier, L; Pageaux, GP; Pinzani, V	1
Centini, G; De Leo, V; Morgante, G; Orvieto, R; Troìa, L	1
Avigan, MI; Brinker, A; Dimick-Santos, L; Jones, SC; Kang, S	1
Bucella, D; Fastrez, M; Revercez, P; Rozenberg, S; Vandromme, J	1
Águas, F; Gomes, C; Guerreiro, F; Martinho, M; Ponte, C; Silva, D; Vilhena, V	1
Alvarez-Navascués, C; Carballo-Folgoso, L; Rodriguez, M	1
Dolmans, MM; Donnez, J	2
De Ponti, F; Gatti, M; Poluzzi, E; Raschi, E	1
Ambrosio, D; Calagna, G; Cianci, A; Colacurci, N; Cucinella, G; De Franciscis, P; Labriola, D; Riemma, G; Schiattarella, A; Vitale, SG	1
Ashkenas, J; Janiszewski, P; Kives, S; Leyland, N; Strand, T; Thiel, J	1
Aloisio, M; Arrigoni, G; Athanasakis, E; Biffi, S; De Spelorzi, YCC; Di Lorenzo, G; Franchin, C; Gaita, B; Licastro, D; Monasta, L; Ricci, G; Romano, F; Scrimin, F; Stabile, G; Ura, B	1
Ekanem, E; Talaulikar, V	1
Mozzanega, B	1
Bet, PM; Drenth, JPH; Hehenkamp, WJK; Huirne, JAF; Middelkoop, MA	1
Agostini, A; Calderon, L; Grob-Vaillant, A; Mancini, J; Netter, A; Siles, P; Vidal, V	1
Egbase, E; Odejinmi, F; Shah, N; Sideris, M	1
Yoon, EL; Yuk, JS	1
Nakano, Y; Osuga, Y; Takanashi, M; Yamauchi, Y	1
D'Oria, O; Gustapane, S; Licchelli, M; Panese, G; Tinelli, A	1
Chodankar, RR; Critchley, HOD; Murray, A; Nicol, M; Whitaker, LHR; Williams, ARW	1
Dinis-Oliveira, RJ	1
Bernal, L; Carmona, F; Carrion, A; Castelo-Branco, C; Feixas, G; Gracia, M; Martínez-Zamora, MÁ; Nicolás, I; Quintas, L; Rius, M	1
Barnott, E; Black, L; Gould, A; Jack, A; Kastora, SL; Kounidas, G; Morgan, D; Poobalan, A; Robinson-Burke, T; Urquhart, G	1
Avilés Dorlhiac, R; Navarro Plazaola, N; Vega Chacana, M	1
Murakawa, H; Nakano, Y; Osuga, Y; Yamauchi, Y	1
Almeida, TA; Báez, D; Bello, AR; Salas, A; Vázquez, P	1
Liu, JH	1
Dinis-Oliveira, RJ; Vieira, DN	1
Capmas, P; Fernandez, H; Pourcelot, AG	1
Chow, TL; Murji, A; Sobel, ML; Whitaker, L	1
De Milliano, I; Hehenkamp, WJK; Huirne, JAF; Ket, JCF; Van Hattum, D	1
Chen, BF; O'Beirne, C; Powell, MC	1
Gilles, C; Manigart, Y; Pazzaglia, E; Praet, J; Rozenberg, S; Vandromme, J	1
Borja De Mozota, D; Kadhel, P; Smail, M	1
Agostini, A; Brun, JL; Darai, E; Descamps, P; Fernandez, H; Koskas, M; Lopès, P	1
Chill, HH; Reuveni Salzman, A; Safrai, M; Shushan, A	1
Cerkez Habek, J; Gulin, D; Habek, D; Hrgovic, I; Hrgovic, Z; Jerkovic Gulin, S	1
Águas, F; Faustino, F; Martinho, M; Reis, J	1
Fernandez, H; Jourdain, O; Lafuma, A; Lehmann, M; Trancart, M; Villefranque, V	1
Duggan, ST; Garnock-Jones, KP	1
Bergeron, C; Chamorro-Santos, C; Crespo-Lora, V; Cruz-Viruel, N; Nogales, FF	1
Britten, J; Catherino, WH; Cox, J; Lewis, T; Malik, M	1
Dan Costa, S; Eggemann, H; Ignatov, A; Ignatov, T	1
Mallick, R; Odejinmi, F; Oliver, R	1
Barreira, M; Courtoy, GE; Dolmans, MM; Donnez, J; Luyckx, M; Marbaix, E	1
Barra, F; Ferrero, S; Vellone, VG	1
Belland, L; Leyland, N; Murji, A; Singh, SS; von Riedemann, S	1
Bergeron, C; Chabbert-Buffet, N; Daraï, E; Fernandez, H	1
Kortekaas, KE; Pelikan, HMP	1
Brun, JL; Froeliger, A; Monseau-Thiburce, AC; Rajaonarison, J; Randriamboavonjy, R; Vogler, A	1
Dutta, D; Powell, M	1
Bouchard, P; Chabbert-Buffet, N; Daraï, E; Kolanska, K	1
Badiani, B; Chiumente, M; Messori, A	1
Courtoy, GE; de Codt, M; Dolmans, MM; Donnez, J; Henriet, P; Luyckx, M; Marbaix, E	1
Al-Hendy, A; Blakesley, RE; Catherino, W; Chan, A; Segars, JH; Simon, JA; Sniukiene, V	1
Arriagada, P; Dolmans, MM; Donnez, J; Donnez, O	2
Baggio, S; Franchi, M; Galeone, F; Pomini, P; Presti, F; Raffaelli, R; Santi, L	1
Ciebiera, M; Jakiel, G; Nowicka, G; Słabuszewska-Jóźwiak, A; Wrzosek, M; Włodarczyk, M	1
Irani, S; Pounds, R; Pradhan, P; Woodhead, N	1
Bae, HS; Jung, YW; Kim, MK; Kim, ML; Seong, SJ; Shim, SS; Yun, BS	1
Courtoy, GE; Dolmans, MM; Donnez, J; Donnez, O	2
Ajossa, S; Corda, V; Giancane, E; Mais, V; Marotto, MF; Melis, GB; Neri, M; Paoletti, AM; Pilloni, M; Piras, B; Saba, A	1
Ambroise, J; Arriagada, P; Courtoy, GE; Dolmans, MM; Donnez, J; Luyckx, M; Marbaix, E	1
Czuczwar, P; Milart, P; Paszkowski, T; Stepniak, A; Wozniak, S	1
Berlit, S; Gabbert, M; Hornemann, A; Sütterlin, M; Tuschy, B; Weiss, C; Wuhrer, A	1
Duffy, JMN; Hirsch, M; Illingworth, BJG	1
Simon, JA	1
Biscette, SM; Ito, T; Jan, AG; Kim, JHJ; Mattingly, PJ	1
Angelico, G; Arciuolo, D; Fanfani, F; Inzani, F; Romualdi, D; Santoro, A; Scambia, G; Zannoni, GF	1
De Gasperis-Brigante, C; Kives, S; Murji, A; Singh, SS; Vilos, G	2
Armstrong, CR; Baig, KM; Brennan, JT; Britten, J; Chang, S; Driggers, PH; Jorge, S; Malik, M; Ng, SSM; Segars, JH; Su, SC	1
Fernandez, H	1
Chan, A; Gee, P; Gillard, P; Harrington, A; Kimble, T; Kroll, R; Liu, JH; Lukes, A; Mallick, M; Shulman, LP; Sniukiene, V; Soper, D	1
Camilli, S; Conway, F; Exacoustos, C; Martire, FG; Morosetti, G; Piccione, E; Sorrenti, G; Zupi, E	1
Arriagada, P; Donnez, J; Larrey, D; Marciniak, M	1
De Wilde, RL; Ebert, AD; Rabe, T; Roemer, T; Saenger, N; Tinneberg, HR; Wallwiener, M	1
Barra, F; Ferrero, S; Scala, C; Vellone, VG	1
Britten, JL; Catherino, WH; Lewis, TD; Malik, M	1
Mallick, R; Odejinmi, F	1
Courtoy, GE; Dolmans, MM; Donnez, J	1
Han, SJ; Hong, YH; Jee, BC; Kim, SK; Lee, D	1
Chang, MC; Latta, E	1
Ajossa, S; Cappai, R; Coghe, F; Corda, V; Giancane, E; Mais, V; Marotto, MF; Melis, GB; Neri, M; Orani, MP; Paoletti, AM; Pilloni, M; Piras, B; Ronchi, A; Saba, A; Vallerino, V; Zedda, P	1
Conzadori, S; Greco, P; Indraccolo, U	1
Britten, J; Catherino, WH; Cox, J; Lewis, TD; Malik, M; Parikh, T	1
Aractingi, S; Bendifallah, S; Bergeron, C; Canlorbe, G; Capmas, P; Chabbert-Buffet, N; Daraï, E; Kolanska, K; Koskas, M; Mekinian, A; Varinot, J	1
Collinet, P; Cosson, M; Giraudet, G; Pécout, M; Rubod, C	1
Al-Hendy, A; Ulin, M; Yang, Q	1
Hatfield, JL	1
Ghonim, M; Magdy, R; Nabhan, A; Sabbour, M	1
Barra, V; Bellone, E; Biscione, A; Luisi, S; Severi, FM	1
Kotarski, J; Szamatowicz, M	1
Driák, D; Sehnal, B; Svandová, I	1
Brazert, M; Korman, MP; Pawelczyk, LA	1
Fuster, S; Higueras, G; Monleón Sancho, J; Morcillo, I; Romaguera, E; Romero, A	1
Barlow, DH; Bestel, E; Fauser, BC; Lumsden, MA; Terrill, P	1
Ágh, T; Józwiak-Hagymásy, J; Kaló, Z; Kovács, G; László, Á; Merész, G; Nagy, B; Timár, G; Vámossy, I; Vokó, Z	1
Biglia, N; Carinelli, S; D'Alonzo, M; Lo Monte, G; Maiorana, A; Marci, R	1
Barlow, DH; Bestel, E; Bouchard, P; Donnez, J; Donnez, O; Fauser, BC; Loumaye, E; Nouri, K; Osterloh, I; Palacios, S; Tomaszewski, J; Vázquez, F	1
Bastianelli, C; Benagiano, G; Brosens, I; Farris, M	1
Closon, F; Firquet, A; Nisolle, M; Pintiaux, A; Top, M	1
Critchley, HO; Whitaker, LH; Williams, AR	1
Gadomska, H; Grzechocinska, B; Wielgos, M; Zygula, A	1
Carrarelli, P; Castellucci, M; Ciarmela, P; Islam, MS; Janjusevic, M; Petraglia, F; Tosti, C; Zupi, E	1
Dolmans, MM; Donnez, J; Donnez, O	2
Gotteland, JP; Pohl, O; Zobrist, RH	1
Dolmans, MM; Donnez, J; Jadoul, P; Luyckx, M; Squifflet, JL; Votino, R	1
Czuczwar, P; Milart, P; Paszkowski, T; Szkodziak, P; Wozniak, S; Wozniakowska, E; Wrona, W	1
Belland, L; Singh, SS	1
Pérez-López, FR	1
Manyonda, I; Talaulikar, VS	2
Arhendt, HJ; Barlow, DH; Bestel, E; Bouchard, P; Donnez, J; Donnez, O; Dumitrascu, MC; Fauser, BC; Fernandez, H; Hudecek, R; Kasilovskiene, Z; Loumaye, E; Matule, D; Osterloh, I; Terrill, P; Zatik, J	1
Galliano, D	1
Bizzarri, N; Candiani, M; Ferrero, S; Leone Roberti Maggiore, U; Scala, C; Tafi, E; Venturini, PL	1
Matytsina, L; Matytsina-Quinlan, L	1
Courtoy, GE; Dolmans, MM; Donnez, J; Marbaix, E	1
Cha, DH; Kim, JY; Kim, ML; Park, JE; Seong, SJ; Shim, JY; Yun, BS	1
Bulun, SE; Moravek, MB	1
Bizzarri, N; Ferrero, S; Ghirardi, V; Remorgida, V; Venturini, PL	1
Sanders, B	1
Ahrendt, HJ; Barlow, DH; Bestel, E; Bouchard, P; Donnez, J; Donnez, O; Dumitrascu, MC; Fauser, BC; Fernandez, H; Hudecek, R; Kasilovskiene, Z; Loumaye, E; Matule, D; Zatik, J	1
Boutas, I; Kalampokas, E; Kalampokas, T; Kamath, M	1
Koskas, M; Luton, D; Puchar, A	1
Abraham, T; Arian, SE; Bartels, CB; Cayton, KC; Chuong, FS; Holthouser, K; Segars, JH	1
Centini, G; Kashani, BN; Morelli, SS; Petraglia, F; Weiss, G	1
Murad, K	1
Arendas, K; Leyland, NA	1
Engl, B; Graziano, A; Lo Monte, G; Marci, R; Piva, I	1
Debiève, F; Dereume, A; Fellah, L; Luyckx, M; Mhallem, M; Pirard, C; Squifflet, J	1
Maratea, D	1
Dubuisson, J; Marci, R; Petignat, P; Willame, A	1
Póka, R; Török, P	1
Cosyns, S; Dony, N; Polyzos, NP	1
Chow, T; Crosier, R; Murji, A; Shirreff, L; Ye, XY	1
Istre, O	1
Postma, MJ; van Asselt, AD; Zakiyah, N	1
Pazzaglia, E; Praet, J; Rozenberg, S; Vandromme, J	1
Arriagada, P; Costa, AP; Fernandez, H; Powell, M; Schmidt, T; Thaler, C	1
Bateman, J; Bougie, O; Islam, S; Singh, S	1
Brodowska, A; Marciniak, A; Nawrocka-Rutkowska, J; Starczewski, A; Szydłowska, I; Wiśniewska, B	1
Critchley, HO; Matthews, R; Murray, AA; Saunders, PT; Shaw, G; Whitaker, LH; Williams, AR	1
Bouchard, P; Chabbert-Buffet, N	1
Bumbuliene, Ž; Costa, AR; Gemzell-Danielsson, K; Heikinheimo, O; Heweker, A; Hudeček, R; Jacquemyn, Y; Melis, GB; Parashar, P; Rechberger, T; Sánchez, AC; Seitz, C; van Aken, B; Zatik, J	1
Arriagada, P; Barlow, DH; Bouchard, P; Donnez, J; Fauser, BC; Lemieszczuk, B; Palacios, S; Skouby, SO; Tomaszewski, J; Vázquez, F; William, AR	1
Bouchard, P	1
Bestel, E; Bouchard, P; Donnez, J; Ivanova, T; Jilla, MP; Loumaye, E; Mara, M; Osterloh, I; Puscasiu, L; Tatarchuk, TF; Terrill, P; Ugocsai, G; Zakharenko, NF	1
Baró, F; Bestel, E; Bouchard, P; Donnez, J; Lemieszczuk, B; Loumaye, E; Nouri, K; Osterloh, I; Selvaggi, L; Sodowski, K; Terrill, P; Tomaszewski, J; Vázquez, F	1
Stewart, EA	1
Croxtall, JD	1
Angiolucci, M; Guerriero, S; Lello, S; Maricosu, G; Marotto, MF; Melis, GB; Orru', MM; Paoletti, AM; Pilloni, M; Piras, B	1
Chaouat, M; Communal, L; Courtin, A; Dumont, S; Forgez, P; Gompel, A; Hugon-Rodin, J; Lahlou, N; Mourra, N; Vilasco, M	1
Manyonda, IT; Talaulikar, VS	1
Barlow, DH; Bergeron, C; Ferenczy, A; Williams, AR	1

Reviews

58 review(s) available for ulipristal acetate and Fibroid

Article	Year
Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids. Human reproduction (Oxford, England), 2022, 05-03, Volume: 37, Issue:5 Topics: Europe; Female; Humans; Leiomyoma; Norpregnadienes; Uterine Neoplasms	2022
The Biological Impact of Ulipristal Acetate on Cellular Networks Regulating Uterine Leiomyoma Growth. Current pharmaceutical design, 2020, Volume: 26, Issue:3 Topics: Adult; Female; Humans; In Vitro Techniques; Leiomyoma; Norpregnadienes; Signal Transduction; Uterine Neoplasms	2020
Ulipristal Acetate Before Hysteroscopic Myomectomy: A Systematic Review. Obstetrical & gynecological survey, 2020, Volume: 75, Issue:2 Topics: Female; Humans; Hysteroscopy; Leiomyoma; Norpregnadienes; Preoperative Care; Receptors, Progesterone; Treatment Outcome; Uterine Myomectomy; Uterine Neoplasms	2020
Acute liver failure requiring transplantation caused by ulipristal acetate. Clinics and research in hepatology and gastroenterology, 2020, Volume: 44, Issue:3 Topics: Chemical and Drug Induced Liver Injury, Chronic; Contraceptive Agents, Female; Female; Humans; Leiomyoma; Liver Failure, Acute; Liver Transplantation; Middle Aged; Norpregnadienes	2020
Hormone therapy for intramural myoma-related infertility from ulipristal acetate to GnRH antagonist: a review. Reproductive biomedicine online, 2020, Volume: 41, Issue:3 Topics: Female; Hormone Antagonists; Humans; Infertility, Female; Leiomyoma; Norpregnadienes; Uterine Neoplasms	2020
Medical Therapy for Fibroids: What Next for Ulipristal Acetate? Advances in therapy, 2021, Volume: 38, Issue:1 Topics: Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Uterine Neoplasms	2021
Risk-efficacy balance of ulipristal acetate compared to surgical alternatives. British journal of clinical pharmacology, 2021, Volume: 87, Issue:7 Topics: Female; Humans; Leiomyoma; Norpregnadienes; Prospective Studies; Quality of Life; Uterine Neoplasms	2021
What happens after randomised controlled trials? Uterine fibroids and ulipristal acetate: systematic review and meta-analysis of "real-world" data. Archives of gynecology and obstetrics, 2021, Volume: 303, Issue:5 Topics: Contraceptive Agents, Hormonal; Female; Humans; Leiomyoma; Norpregnadienes; Prospective Studies; Randomized Controlled Trials as Topic	2021
Efficacy of ulipristal acetate in women with fibroid induced menorrhagia: A systematic review and meta-analysis. Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:9 Topics: Adult; Contraceptive Agents; Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Uterine Neoplasms	2021
Effects of ulipristal acetate in patients with symptomatic uterine fibroids. Medwave, 2021, May-07, Volume: 21, Issue:4 Topics: Female; Humans; Leiomyoma; Norpregnadienes; Quality of Life; Systematic Reviews as Topic; Treatment Outcome; Uterine Neoplasms	2021
Place of ulipristal acetate in the management of uterine fibroids: Preoperative treatment or sequential treatment? Journal of gynecology obstetrics and human reproduction, 2017, Volume: 46, Issue:3 Topics: Contraceptive Agents, Female; Female; Fertility; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Preoperative Care; Receptors, Progesterone; Uterine Neoplasms	2017
Selective progesterone receptor modulators (SPRMs) for uterine fibroids. The Cochrane database of systematic reviews, 2017, Apr-26, Volume: 4 Topics: Amenorrhea; Antineoplastic Agents, Hormonal; Estrenes; Female; Humans; Leiomyoma; Leuprolide; Menstruation; Mifepristone; Norpregnadienes; Oximes; Pelvic Pain; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms	2017
Endometrial changes during ulipristal acetate use: A systematic review. European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 214 Topics: Contraceptive Agents, Female; Endometrium; Female; Humans; Leiomyoma; Norpregnadienes	2017
The use of selective progestin receptor modulators (SPRMs) and more specifically ulipristal acetate in the practice of gynaecology. The Australian & New Zealand journal of obstetrics & gynaecology, 2017, Volume: 57, Issue:4 Topics: Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Female; Humans; Leiomyoma; Norpregnadienes; Receptors, Progesterone; Uterine Neoplasms	2017
Update on medical treatment of uterine fibroids. European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 216 Topics: Adult; Contraceptive Agents, Female; Female; Humans; Leiomyoma; Norpregnadienes; Quality of Life; Uterine Neoplasms	2017
Ulipristal Acetate: A Review in Symptomatic Uterine Fibroids. Drugs, 2017, Volume: 77, Issue:15 Topics: Dose-Response Relationship, Drug; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Norpregnadienes; Receptors, Progesterone	2017
Is ulipristal acetate the new drug of choice for the medical management of uterine fibroids? Res ipsa loquitur? Women's health (London, England), 2017, Volume: 13, Issue:3 Topics: Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Leiomyoma; Norpregnadienes; Severity of Illness Index; Uterine Neoplasms; Women's Health	2017
Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids. Expert opinion on drug metabolism & toxicology, 2018, Volume: 14, Issue:1 Topics: Administration, Oral; Animals; Biological Availability; Female; Humans; Leiomyoma; Norpregnadienes; Receptors, Progesterone; Time Factors; Uterine Neoplasms	2018
The past, present, and future of selective progesterone receptor modulators in the management of uterine fibroids. American journal of obstetrics and gynecology, 2018, Volume: 218, Issue:6 Topics: Contraceptive Agents, Female; Disease Management; Estrenes; Female; Forecasting; Humans; Leiomyoma; Mifepristone; Norpregnadienes; Oximes; Population Growth; Receptors, Progesterone; Steroids; Uterine Neoplasms	2018
Esmya Women's health (London, England), 2016, Volume: 12, Issue:6 Topics: Adult; Clinical Trials, Phase III as Topic; Contraceptive Agents, Female; Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Uterine Hemorrhage; Uterine Neoplasms	2016
Selective progesterone receptor modulators: current applications and perspectives. Climacteric : the journal of the International Menopause Society, 2018, Volume: 21, Issue:4 Topics: Abortion, Induced; Endometriosis; Female; Humans; Leiomyoma; Mifepristone; Norpregnadienes; Pregnancy; Progesterone; Receptors, Progesterone; Uterine Hemorrhage; Uterine Neoplasms	2018
Emerging treatment options for uterine fibroids. Expert opinion on emerging drugs, 2018, Volume: 23, Issue:1 Topics: Drug Design; Female; Fertility Preservation; Humans; Leiomyoma; Norpregnadienes; Receptors, Progesterone; Uterine Neoplasms	2018
Ulipristal acetate for the management of large uterine fibroids associated with heavy bleeding: a review. Reproductive biomedicine online, 2018, Volume: 37, Issue:2 Topics: Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Quality of Life; Treatment Outcome; Uterine Neoplasms	2018
Vilaprisan for treating uterine fibroids. Expert opinion on investigational drugs, 2018, Volume: 27, Issue:5 Topics: Animals; Female; Humans; Leiomyoma; Norpregnadienes; Receptors, Progesterone; Steroids; Time Factors; Uterine Hemorrhage; Uterine Neoplasms	2018
Alternatives to excisional therapy: a clinical review of our current options to conservatively manage symptomatic leiomyomas. Current opinion in obstetrics & gynecology, 2018, Volume: 30, Issue:4 Topics: Antifibrinolytic Agents; Aromatase Inhibitors; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Magnetic Resonance Imaging, Interventional; Norpregnadienes; Radiofrequency Ablation; Receptors, Progesterone; Tranexamic Acid; Ultrasonic Therapy; Uterine Artery Embolization; Uterine Neoplasms	2018
Pregnancy Outcomes Following Ulipristal Acetate for Uterine Fibroids: A Systematic Review. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2018, Volume: 40, Issue:8 Topics: Canada; Female; Humans; Leiomyoma; Norpregnadienes; Pregnancy; Pregnancy Outcome; Uterine Neoplasms	2018
Liver safety parameters of ulipristal acetate for the treatment of uterine fibroids: a comprehensive review of the clinical development program. Expert opinion on drug safety, 2018, Volume: 17, Issue:12 Topics: Chemical and Drug Induced Liver Injury; Contraceptive Agents, Female; Female; Humans; Leiomyoma; Liver Function Tests; Norpregnadienes; Uterine Neoplasms	2018
Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate. BioMed research international, 2018, Volume: 2018 Topics: Female; Humans; Leiomyoma; Norpregnadienes; Practice Patterns, Physicians'; Receptors, Progesterone; Uterine Neoplasms	2018
Ulipristal Acetate before Hysteroscopic and Laparoscopic Surgery for Uterine Myomas: Help or Hindrance? Gynecologic and obstetric investigation, 2019, Volume: 84, Issue:4 Topics: Adult; Endometrium; Female; Humans; Hysteroscopy; Laparoscopy; Leiomyoma; Middle Aged; Norpregnadienes; Preoperative Period; Prospective Studies; Retrospective Studies; Treatment Outcome; Uterine Myomectomy; Uterine Neoplasms	2019
Fibroid management in premenopausal women. Climacteric : the journal of the International Menopause Society, 2019, Volume: 22, Issue:1 Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Hysterectomy; Leiomyoma; Norpregnadienes; Premenopause; Preoperative Care; Progesterone; Randomized Controlled Trials as Topic; Risk Factors; Uterine Neoplasms	2019
A systematic review and meta-analysis of ulipristal acetate for symptomatic uterine fibroids. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2019, Volume: 146, Issue:2 Topics: Adult; Amenorrhea; Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Quality of Life; Randomized Controlled Trials as Topic; Uterine Neoplasms	2019
[Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women]. Ginekologia polska, 2013, Volume: 84, Issue:3 Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hormone Antagonists; Humans; Leiomyoma; Norpregnadienes; Progesterone; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms	2013
[Applicability of selective progesterone receptor modulators in the treatment of uterine leiomyomata and their future role in the field of gynecology]. Ginekologia polska, 2013, Volume: 84, Issue:9 Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hormone Antagonists; Humans; Leiomyoma; Norpregnadienes; Progesterone; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms	2013
[Ulipristal acetate, 5mg: a new alternative]. Medicina clinica, 2013, Volume: 141 Suppl 1 Topics: Antineoplastic Agents, Hormonal; Female; Humans; Leiomyoma; Norpregnadienes; Treatment Outcome; Uterine Neoplasms	2013
Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids. Drug design, development and therapy, 2014, Volume: 8 Topics: Endometrium; Female; Humans; Leiomyoma; Norpregnadienes	2014
Selective progesterone receptor modulators: an update. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:10 Topics: Adenomyosis; Animals; Clinical Trials as Topic; Contraception, Postcoital; Contraceptive Agents, Female; Contraceptives, Postcoital; Endometriosis; Estrenes; Female; Hormone Antagonists; Humans; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone; Uterine Neoplasms	2014
Selective progesterone receptor modulators. Current opinion in obstetrics & gynecology, 2014, Volume: 26, Issue:4 Topics: Breast Neoplasms; Contraceptives, Postcoital; Endometriosis; Female; Hormone Antagonists; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Quality of Life; Receptors, Progesterone; Uterine Neoplasms	2014
With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice? Fertility and sterility, 2014, Volume: 102, Issue:3 Topics: Antineoplastic Agents, Hormonal; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Laparoscopy; Leiomyoma; Norpregnadienes; Practice Guidelines as Topic; Progestins; Receptors, Progesterone; Uterine Neoplasms	2014
The clinical pharmacology and pharmacokinetics of ulipristal acetate for the treatment of uterine fibroids. Reproductive sciences (Thousand Oaks, Calif.), 2015, Volume: 22, Issue:4 Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Biological Availability; Biotransformation; Cytochrome P-450 CYP3A; Drug Administration Schedule; Drug Interactions; Female; Half-Life; Humans; Leiomyoma; Norpregnadienes; Risk Assessment; Uterine Neoplasms	2015
Contemporary management of uterine fibroids: focus on emerging medical treatments. Current medical research and opinion, 2015, Volume: 31, Issue:1 Topics: Adult; Canada; Female; Gynecologic Surgical Procedures; Hormone Antagonists; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Uterine Neoplasms; Watchful Waiting	2015
Ulipristal acetate in the management of symptomatic uterine fibroids: facts and pending issues. Climacteric : the journal of the International Menopause Society, 2015, Volume: 18, Issue:2 Topics: Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Quality of Life; Receptors, Progesterone; Uterine Hemorrhage; Uterine Neoplasms	2015
Ulipristal acetate in uterine fibroids. Fertility and sterility, 2015, Volume: 103, Issue:2 Topics: Female; Humans; Leiomyoma; Norpregnadienes; Quality of Life; Uterine Neoplasms	2015
Drug safety evaluation of ulipristal acetate in the treatment of uterine fibroids. Expert opinion on drug safety, 2015, Volume: 14, Issue:6 Topics: Animals; Apoptosis; Cell Proliferation; Female; Humans; Leiomyoma; Norpregnadienes; Quality of Life; Receptors, Progesterone; Time Factors; Uterine Neoplasms	2015
Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution. Current opinion in obstetrics & gynecology, 2015, Volume: 27, Issue:4 Topics: DNA Mutational Analysis; Estrogens; Exons; Female; Genetic Predisposition to Disease; Genotype; HMGA2 Protein; Hormones; Humans; Leiomyoma; Mediator Complex; Mutation; Norpregnadienes; Progesterone; Uterine Neoplasms	2015
Current management of myomas: the place of medical therapy with the advent of selective progesterone receptor modulators. Current opinion in obstetrics & gynecology, 2015, Volume: 27, Issue:6 Topics: Adult; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Patient Selection; Receptors, Progesterone; Treatment Outcome; Uterine Neoplasms	2015
Ulipristal acetate for uterine fibroids: a systematic review and meta-analysis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016, Volume: 32, Issue:2 Topics: Female; Humans; Leiomyoma; Norpregnadienes; Receptors, Progesterone; Uterine Neoplasms	2016
Ulipristal acetate for uterine fibroid-related symptoms. Drugs of today (Barcelona, Spain : 1998), 2015, Volume: 51, Issue:11 Topics: Animals; Clinical Trials as Topic; Drug Interactions; Female; Humans; Leiomyoma; Norpregnadienes; Receptors, Progesterone; Uterine Neoplasms	2015
An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review. Clinical obstetrics and gynecology, 2016, Volume: 59, Issue:1 Topics: Androgens; Aromatase Inhibitors; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Curcumin; Delayed-Action Preparations; Drugs, Chinese Herbal; Estradiol; Estrenes; Estrogen Receptor Antagonists; Evidence-Based Medicine; Female; Fulvestrant; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Neoadjuvant Therapy; Norpregnadienes; Oximes; Plant Extracts; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tea; Uterine Myomectomy; Uterine Neoplasms; Vitamin D; Vitamins	2016
Role of Medical Management for Uterine Leiomyomas. Best practice & research. Clinical obstetrics & gynaecology, 2016, Volume: 34 Topics: Antifibrinolytic Agents; Aromatase Inhibitors; Cabergoline; Cholecalciferol; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Danazol; Dopamine Agonists; Ergolines; Estrenes; Estrogen Antagonists; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Patient Care Planning; Selective Estrogen Receptor Modulators; Somatostatin; Tranexamic Acid; Uterine Neoplasms; Vitamins	2016
The place of selective progesterone receptor modulators in myoma therapy. Minerva ginecologica, 2016, Volume: 68, Issue:3 Topics: Female; Humans; Leiomyoma; Norpregnadienes; Progesterone; Receptors, Progesterone; Uterine Hemorrhage; Uterine Neoplasms	2016
Uterine fibroid management: from the present to the future. Human reproduction update, 2016, Volume: 22, Issue:6 Topics: Contraceptive Agents; Female; Humans; Hysterectomy; Leiomyoma; Magnetic Resonance Imaging; Norpregnadienes; Pelvic Pain; Progesterone; Randomized Controlled Trials as Topic; Risk Factors; Uterine Artery; Uterine Neoplasms	2016
Safety of treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate. Expert opinion on drug safety, 2016, Volume: 15, Issue:12 Topics: Female; Humans; Leiomyoma; Norpregnadienes; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms	2016
[New methods of uterine fibroids treatment]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2016, Dec-22, Volume: 41, Issue:246 Topics: Antineoplastic Agents; Female; High-Intensity Focused Ultrasound Ablation; Humans; Leiomyoma; Norpregnadienes; Uterine Neoplasms	2016
The history and use of the progesterone receptor modulator ulipristal acetate for heavy menstrual bleeding with uterine fibroids. Best practice & research. Clinical obstetrics & gynaecology, 2017, Volume: 40 Topics: Administration, Oral; Drug Administration Schedule; Endometrium; Female; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Randomized Controlled Trials as Topic; Receptors, Progesterone	2017
Current and future medical treatments for menometrorrhagia during the premenopause. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2011, Volume: 27 Suppl 1 Topics: Adolescent; Adult; Contraceptives, Oral; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Metrorrhagia; Mifepristone; Norpregnadienes; Polyps; Premenopause; Progestins; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms	2011
Ulipristal acetate: in uterine fibroids. Drugs, 2012, May-28, Volume: 72, Issue:8 Topics: Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Humans; Leiomyoma; Norpregnadienes; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Uterine Neoplasms	2012
Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids. European journal of obstetrics, gynecology, and reproductive biology, 2012, Volume: 165, Issue:2 Topics: Endometrium; Estrenes; Female; Hormone Antagonists; Humans; Hyperplasia; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone	2012
Ulipristal acetate: a novel option for the medical management of symptomatic uterine fibroids. Advances in therapy, 2012, Volume: 29, Issue:8 Topics: Adult; Age Factors; Cohort Studies; Contraceptive Agents; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hysterectomy; Leiomyoma; Middle Aged; Needs Assessment; Norpregnadienes; Quality of Life; Risk Assessment; Severity of Illness Index; Treatment Outcome; United Kingdom; Uterine Neoplasms	2012

Trials

21 trial(s) available for ulipristal acetate and Fibroid

Article	Year
The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation. Breast cancer research and treatment, 2022, Volume: 192, Issue:2 Topics: Adolescent; Adult; Breast Neoplasms; Cell Proliferation; Female; Humans; Leiomyoma; Norpregnadienes; Progesterone; Receptors, Progesterone; Young Adult	2022
Efficacy and Safety of Repeated Use of Ulipristal Acetate in Uterine Fibroids. Mymensingh medical journal : MMJ, 2023, Volume: 32, Issue:1 Topics: Bangladesh; Female; Humans; Leiomyoma; Quality of Life; Uterine Neoplasms	2023
Ulipristal acetate vs gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Short-term results of a double-blind randomized controlled trial. Acta obstetricia et gynecologica Scandinavica, 2020, Volume: 99, Issue:1 Topics: Adult; Blood Loss, Surgical; Contraceptive Agents, Hormonal; Double-Blind Method; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Leiomyoma; Netherlands; Norpregnadienes; Operative Time; Sutures; Uterine Myomectomy; Uterine Neoplasms	2020
Effect on surgical decisions: Ulipristal acetate as key player in Belgian phase IV registration trial. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2019, Volume: 147, Issue:3 Topics: Adult; Belgium; Female; Humans; Leiomyoma; Norpregnadienes; Preoperative Period; Prospective Studies; Treatment Outcome; Uterine Myomectomy; Uterine Neoplasms	2019
Preoperative Treatment with Ulipristal Acetate before Outpatient Hysteroscopic Myomectomy. Gynecologic and obstetric investigation, 2020, Volume: 85, Issue:2 Topics: Adult; Ambulatory Surgical Procedures; Combined Modality Therapy; Contraceptive Agents, Hormonal; Female; Humans; Hysteroscopy; Leiomyoma; Middle Aged; Norpregnadienes; Operative Time; Patient Preference; Pregnancy; Preoperative Care; Prospective Studies; Treatment Outcome; Uterine Myomectomy; Uterine Neoplasms	2020
Steroid hormones and hormone antagonists regulate the neural marker neurotrimin in uterine leiomyoma. Fertility and sterility, 2020, Volume: 113, Issue:1 Topics: Biomarkers; Cell Line, Tumor; Contraceptive Agents, Female; Double-Blind Method; Estradiol; Female; Gonadal Steroid Hormones; GPI-Linked Proteins; Hormone Antagonists; Humans; Leiomyoma; Neural Cell Adhesion Molecules; Norpregnadienes	2020
Ulipristal acetate before in vitro fertilization: efficacy in infertile women with submucous fibroids. Reproductive biology and endocrinology : RB&E, 2020, May-19, Volume: 18, Issue:1 Topics: Adult; Female; Fertilization in Vitro; Humans; Infertility, Female; Leiomyoma; Norpregnadienes; Preconception Care; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Rate; Treatment Outcome; Uterine Neoplasms; Uterus	2020
Ulipristal acetate compared with leuprorelin acetate for Japanese women with symptomatic uterine fibroids: a phase III randomized controlled trial. Fertility and sterility, 2021, Volume: 116, Issue:1 Topics: Adult; Amenorrhea; Double-Blind Method; Female; Humans; Japan; Leiomyoma; Leuprolide; Menorrhagia; Middle Aged; Norpregnadienes; Time Factors; Treatment Outcome; Uterine Neoplasms	2021
Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial. Reproductive sciences (Thousand Oaks, Calif.), 2018, Volume: 25, Issue:2 Topics: Antineoplastic Agents, Hormonal; Double-Blind Method; Extracellular Matrix; Extracellular Matrix Proteins; Female; Humans; Leiomyoma; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myometrium; Norpregnadienes; Uterine Neoplasms	2018
Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial. Obstetrics and gynecology, 2018, Volume: 131, Issue:3 Topics: Administration, Oral; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Hormone Antagonists; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Treatment Outcome; Uterine Neoplasms	2018
Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial. Obstetrics and gynecology, 2018, Volume: 132, Issue:5 Topics: Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Cross-Over Studies; Double-Blind Method; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Quality of Life; Surveys and Questionnaires; Symptom Assessment; Uterine Hemorrhage; Uterine Neoplasms	2018
Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo. Human reproduction (Oxford, England), 2014, Volume: 29, Issue:3 Topics: Adolescent; Adult; Amenorrhea; Double-Blind Method; Female; Humans; Leiomyoma; Menorrhagia; Middle Aged; Norpregnadienes; Uterine Hemorrhage; Uterine Neoplasms	2014
Long-term treatment of uterine fibroids with ulipristal acetate ☆. Fertility and sterility, 2014, Volume: 101, Issue:6 Topics: Administration, Oral; Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Drug Administration Schedule; Endometrium; Europe; Female; Humans; Leiomyoma; Menorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnadienes; Pelvic Pain; Quality of Life; Time Factors; Treatment Outcome; Tumor Burden; Uterine Neoplasms	2014
First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids. Fertility and sterility, 2014, Volume: 102, Issue:5 Topics: Abortion, Spontaneous; Adult; Antineoplastic Agents; Contraceptive Agents; Female; Humans; Leiomyoma; Live Birth; Norpregnadienes; Pilot Projects; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Treatment Outcome; Uterine Neoplasms	2014
Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertility and sterility, 2015, Volume: 103, Issue:2 Topics: Administration, Oral; Adult; Amenorrhea; Double-Blind Method; Female; Headache; Humans; Leiomyoma; Middle Aged; Nausea; Norpregnadienes; Pain; Quality of Life; Treatment Outcome; Uterine Neoplasms	2015
In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment. Fertility and sterility, 2015, Volume: 104, Issue:2 Topics: Adult; Contraceptive Agents; Double-Blind Method; Female; Humans; Leiomyoma; Middle Aged; Myoma; Norpregnadienes; Preoperative Care; Treatment Outcome; Uterine Neoplasms	2015
Long-term medical management of uterine fibroids with ulipristal acetate. Fertility and sterility, 2016, Volume: 105, Issue:1 Topics: Adolescent; Adult; Antineoplastic Agents; Biopsy; Double-Blind Method; Drug Administration Schedule; Europe; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Pain Measurement; Pelvic Pain; Quality of Life; Surveys and Questionnaires; Time Factors; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms; Young Adult	2016
Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids. Contemporary clinical trials, 2017, Volume: 55 Topics: Adolescent; Adult; Contraceptive Agents, Female; Double-Blind Method; Drug Administration Schedule; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Quality of Life; Research Design; Steroids; Young Adult	2017
Ulipristal acetate versus placebo for fibroid treatment before surgery. The New England journal of medicine, 2012, Feb-02, Volume: 366, Issue:5 Topics: Administration, Oral; Adult; Anemia; Double-Blind Method; Female; Humans; Intention to Treat Analysis; Leiomyoma; Menorrhagia; Middle Aged; Norpregnadienes; Receptors, Progesterone; Uterine Neoplasms; Uterus; Young Adult	2012
Ulipristal acetate versus leuprolide acetate for uterine fibroids. The New England journal of medicine, 2012, Feb-02, Volume: 366, Issue:5 Topics: Administration, Oral; Adult; Double-Blind Method; Endometrium; Female; Humans; Injections, Intramuscular; Intention to Treat Analysis; Leiomyoma; Leuprolide; Menorrhagia; Middle Aged; Norpregnadienes; Uterine Neoplasms; Young Adult	2012
Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2012, Volume: 31, Issue:6 Topics: Adolescent; Adult; Biopsy; Double-Blind Method; Endometrial Hyperplasia; Endometrium; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Receptors, Progesterone	2012

Other Studies

105 other study(ies) available for ulipristal acetate and Fibroid

Article	Year
Ultrasonographic appearance of the endometrium after saline infusion in women presenting with PRM-associated endometrial changes, due to the use of ulipristal acetate. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2022, Volume: 42, Issue:7 Topics: Endometrium; Female; Humans; Hysteroscopy; Leiomyoma; Norpregnadienes; Pregnancy	2022
Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate. Human molecular genetics, 2023, 03-20, Volume: 32, Issue:7 Topics: Female; Humans; Leiomyoma; Receptors, Progesterone; Retrospective Studies; Transcription Factors; Uterine Neoplasms	2023
Effects of long-term intermittent pharmacological therapy with ulipristal acetate on reducing the volume of uterine fibroids and relieving symptoms. Minerva obstetrics and gynecology, 2023, Volume: 75, Issue:3 Topics: Adult; Contraceptive Agents, Female; Contraceptive Agents, Hormonal; Female; Humans; Leiomyoma; Menorrhagia; Middle Aged; Norpregnadienes; Treatment Outcome; Uterine Neoplasms	2023
Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 168 Topics: Animals; Cell Death; Chemokine CCL2; DNA, Complementary; Female; Humans; Leiomyoma; Mice; Receptors, Progesterone; Sarcoma; Signal Transduction; STAT3 Transcription Factor; Uterine Neoplasms	2023
Ulipristal acetate in symptomatic uterine fibroids. A real-world experience in a multicentric Italian study. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:2 Topics: Adolescent; Adult; Female; Humans; Italy; Leiomyoma; Middle Aged; Norpregnadienes; Retrospective Studies; Treatment Outcome; Uterine Neoplasms; Young Adult	2020
Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2019, Volume: 41, Issue:10 Topics: Anemia; Antineoplastic Agents, Hormonal; Contraceptive Agents, Hormonal; Female; Gonadotropin-Releasing Hormone; Hematinics; Humans; Iron Compounds; Leiomyoma; Leuprolide; Liver Function Tests; Menorrhagia; Norpregnadienes; Uterine Neoplasms	2019
Predictors of uterine fibroid volume reduction under ulipristal acetate: a prospective MRI study. Reproductive biomedicine online, 2019, Volume: 39, Issue:5 Topics: Adult; Body Mass Index; Female; Humans; Leiomyoma; Magnetic Resonance Imaging; Middle Aged; Norpregnadienes; Prospective Studies; Treatment Outcome	2019
Liver function, tolerability and satisfaction during treatment with ulipristal acetate in women with fibroids: a single center experience. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:5 Topics: Adult; Contraceptive Agents, Hormonal; Cross-Sectional Studies; Female; Humans; Leiomyoma; Liver; Liver Function Tests; Middle Aged; Norpregnadienes; Uterine Neoplasms	2020
The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor. The Journal of clinical endocrinology and metabolism, 2020, 03-01, Volume: 105, Issue:3 Topics: Adult; Animals; Cell Line, Tumor; Dexamethasone; Female; Gene Expression Profiling; Gene Expression Regulation; Humans; Leiomyoma; Mice; Models, Animal; Norpregnadienes; Period Circadian Proteins; Primary Cell Culture; Product Surveillance, Postmarketing; Receptors, Glucocorticoid; Signal Transduction; Tacrolimus Binding Proteins; Transcription Factors; Uterine Neoplasms; Uterus	2020
Differences in fibroid vascularity after three months of pre-treatment with leuprolide acetate or ulipristal acetate: A pilot study. European journal of obstetrics, gynecology, and reproductive biology, 2020, Volume: 245 Topics: Adult; Antineoplastic Agents, Hormonal; Female; Humans; Leiomyoma; Leuprolide; Neovascularization, Pathologic; Netherlands; Norpregnadienes; Pilot Projects; Premenopause; Treatment Outcome; Tumor Burden; Uterine Neoplasms	2020
EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model. Scientific reports, 2019, 11-21, Volume: 9, Issue:1 Topics: Animals; Cell Proliferation; Contraceptive Agents, Female; Estrenes; Female; Humans; Leiomyoma; Mice; Molecular Docking Simulation; Molecular Structure; Norpregnadienes; Oximes; Progesterone Congeners; Receptors, Progesterone; Structure-Activity Relationship; Uterine Neoplasms; Uterus; Xenograft Model Antitumor Assays	2019
Shrinking leiomyomas by pharmacological autophagy other than surgical removal. Fertility and sterility, 2019, Volume: 112, Issue:6 Topics: Autophagy; Humans; Leiomyoma; Norpregnadienes; Up-Regulation	2019
Autophagy up-regulation by ulipristal acetate as a novel target mechanism in the treatment of uterine leiomyoma: an in vitro study. Fertility and sterility, 2019, Volume: 112, Issue:6 Topics: Adult; Antineoplastic Agents, Hormonal; Autophagy; Autophagy-Related Proteins; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Signal Transduction; Tumor Cells, Cultured; Uterine Neoplasms	2019
Efficacy of ulipristal acetate (UPA) for the treatment of expulsion uterine myomas: report of two cases. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:7 Topics: Blood Transfusion; Emergencies; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Rupture, Spontaneous; Uterine Hemorrhage; Uterine Neoplasms	2020
What does non-eligibility for myoma surgery mean in the context of sequential prescription of ulipristal acetate? Journal of gynecology obstetrics and human reproduction, 2020, Volume: 49, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Contraindications, Procedure; Female; Humans; Leiomyoma; Norpregnadienes; Risk Factors; Uterine Myomectomy; Uterine Neoplasms	2020
An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids. Drug safety, 2020, Volume: 43, Issue:12 Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Leiomyoma; Norpregnadienes; Product Surveillance, Postmarketing; United States; Uterine Neoplasms	2020
Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic! European journal of obstetrics, gynecology, and reproductive biology, 2020, Volume: 252 Topics: Adult; Aged; Betacoronavirus; Chemical and Drug Induced Liver Injury; Coronavirus Infections; COVID-19; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Pandemics; Pneumonia, Viral; Risk Assessment; Risk Factors; Safety-Based Drug Withdrawals; SARS-CoV-2; Substance Withdrawal Syndrome; Uterine Neoplasms; Withholding Treatment	2020
Management of symptomatic uterine fibroids with ulipristal acetate: A retrospective, multicentric and nationwide study. Journal of gynecology obstetrics and human reproduction, 2020, Volume: 49, Issue:8 Topics: Adolescent; Adult; Anemia; Contraceptive Agents, Hormonal; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Portugal; Pregnancy; Retrospective Studies; Treatment Outcome; Uterine Hemorrhage; Young Adult	2020
Acute Liver Failure Associated With Ulipristal Acetate: A Case Report. The American journal of gastroenterology, 2020, Volume: 115, Issue:9 Topics: Contraceptive Agents, Hormonal; Female; Humans; Leiomyoma; Liver Failure, Acute; Middle Aged; Norpregnadienes	2020
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis. Drug safety, 2020, Volume: 43, Issue:12 Topics: Chemical and Drug Induced Liver Injury; Confounding Factors, Epidemiologic; Female; Humans; Leiomyoma; Norpregnadienes; Pharmacovigilance; Retrospective Studies; United States; Uterine Neoplasms	2020
Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study. Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy, 2022, Volume: 31, Issue:3 Topics: Female; Humans; Hysteroscopy; Leiomyoma; Myoma; Norpregnadienes; Pregnancy; Prospective Studies; Uterine Neoplasms	2022
Treatment Choices in a National Cohort of Canadian Women With Symptomatic Uterine Fibroids. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2020, Volume: 42, Issue:12 Topics: Adult; Canada; Contraceptive Agents, Female; Contraceptive Agents, Hormonal; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Middle Aged; Norpregnadienes; Pregnancy; Treatment Outcome; Uterine Myomectomy; Uterine Neoplasms; Watchful Waiting	2020
Proteins involved in oxidative stress in leiomyoma tissues treated with ulipristal acetate. Molecular medicine reports, 2021, Volume: 23, Issue:1 Topics: Adult; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Hydrogen Peroxide; Leiomyoma; Mass Spectrometry; Norpregnadienes; Oxidative Stress; Protein Interaction Maps; Proteomics; Reactive Oxygen Species; Uterine Neoplasms	2021
Ulipristal acetate and liver-injuries: while Esmya is revoked, EllaOne is allowed in repeated self-administrations possibly exceeding UPA toxic-dosing with Esmya. Journal of hepatology, 2021, Volume: 74, Issue:3 Topics: Awareness; Chemical and Drug Induced Liver Injury; Contraception, Postcoital; Contraceptive Agents, Female; Female; Humans; Leiomyoma; Norpregnadienes; Receptors, Progesterone; Self Administration; Treatment Outcome	2021
Progression of adenomyosis magnetic resonance imaging features under ulipristal acetate for symptomatic fibroids. Reproductive biomedicine online, 2021, Volume: 42, Issue:3 Topics: Adenomyosis; Adult; Contraceptive Agents, Female; Disease Progression; Female; Humans; Leiomyoma; Magnetic Resonance Imaging; Norpregnadienes; Pilot Projects; Prospective Studies	2021
Use of Ulipristal Acetate and Risk of Liver Disease: A Nationwide Cohort Study. The Journal of clinical endocrinology and metabolism, 2021, 05-13, Volume: 106, Issue:6 Topics: Adult; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Humans; Incidence; Leiomyoma; Liver Diseases; Middle Aged; Norpregnadienes; Republic of Korea; Retrospective Studies; Risk Factors; Uterine Hemorrhage; Uterine Neoplasms	2021
Nutraceuticals in fibroid management after ulipristal acetate administration: An observational study on patients' compliance. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 156, Issue:1 Topics: Adult; Dietary Supplements; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Quality of Life; Uterine Neoplasms	2022
The endometrial response to modulation of ligand-progesterone receptor pathways is reversible. Fertility and sterility, 2021, Volume: 116, Issue:3 Topics: Adenomyosis; Adult; Cross-Sectional Studies; Endometrium; Female; Gene Expression Regulation; Humans; Leiomyoma; Ligands; Menorrhagia; Middle Aged; Norpregnadienes; Receptors, Progesterone; RNA, Messenger; Time Factors; Treatment Outcome; Uterine Neoplasms	2021
Pharmacokinetics, toxicological and clinical aspects of ulipristal acetate: insights into the mechanisms implicated in the hepatic toxicity. Drug metabolism reviews, 2021, Volume: 53, Issue:3 Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Leiomyoma; Norpregnadienes; Uterine Neoplasms	2021
Management of symptomatic uterine fibroids after ulipristal acetate suspension and identification of high risk patients for surgery at 6-months of follow-up. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2021, Volume: 37, Issue:9 Topics: Adult; Contraceptive Agents, Hormonal; Female; Humans; Legislation, Drug; Leiomyoma; Middle Aged; Norpregnadienes; Prospective Studies; Quality of Life; Risk Factors; Uterine Neoplasms	2021
Phase III long-term study to evaluate the efficacy and safety of ulipristal acetate in Japanese patients with uterine fibroids. The journal of obstetrics and gynaecology research, 2021, Volume: 47, Issue:9 Topics: Female; Humans; Japan; Leiomyoma; Norpregnadienes; Quality of Life; Uterine Neoplasms	2021
Dual agonist-antagonist effect of ulipristal acetate in human endometrium and myometrium. Expert review of molecular diagnostics, 2021, Volume: 21, Issue:8 Topics: Endometrium; Female; Humans; Leiomyoma; Myometrium; Norpregnadienes	2021
Medical treatment with ulipristal acetate for uterine fibroids: Will it be resurrected? Fertility and sterility, 2021, Volume: 116, Issue:1 Topics: Humans; Leiomyoma; Norpregnadienes	2021
Acute liver failure requiring transplantation: A possible link to ulipristal acetate treatment? Basic & clinical pharmacology & toxicology, 2021, Volume: 129, Issue:3 Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Leiomyoma; Liver; Liver Failure, Acute; Liver Function Tests; Liver Transplantation; Middle Aged; Norpregnadienes; Risk Assessment; Risk Factors	2021
An observation study of the clinical evaluation of symptom relief and side effects associated with taking ulipristal acetate (esmya) including its effect on pre-menstrual syndrome. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2017, Volume: 37, Issue:5 Topics: Adult; Contraceptive Agents, Female; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Premenstrual Syndrome	2017
Inefficiency of ulipristal acetate on uterus leiomyomas as an additional sign to suspect leiomyosarcoma. Journal of gynecology obstetrics and human reproduction, 2017, Volume: 46, Issue:7 Topics: Adult; Combined Modality Therapy; Diagnosis, Differential; Drug Resistance, Neoplasm; Female; Humans; Hysterectomy; Leiomyoma; Leiomyosarcoma; Morcellation; Norpregnadienes; Preoperative Care; Treatment Failure; Tumor Burden; Uterine Neoplasms	2017
Real-world data of 197 patients treated with ulipristal acetate for uterine fibroids: PREMYA study French population main outcomes. Journal of gynecology obstetrics and human reproduction, 2017, Volume: 46, Issue:7 Topics: Adult; Combined Modality Therapy; Female; France; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Practice Patterns, Physicians'; Preoperative Period; Prospective Studies; Quality of Life; Treatment Outcome; Uterine Neoplasms	2017
Selective Progesterone Receptor Modulators for the Treatment of Uterine Leiomyomas. Obstetrics and gynecology, 2017, Volume: 130, Issue:2 Topics: Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Norpregnadienes; Receptors, Progesterone; Uterine Neoplasms	2017
Spontaneous pregnancy during ulipristal acetate treatment of giant uterine leiomyoma. Journal of clinical pharmacy and therapeutics, 2018, Volume: 43, Issue:1 Topics: Adult; Contraception, Postcoital; Female; Humans; Leiomyoma; Norpregnadienes; Pregnancy; Receptors, Progesterone	2018
Economic impact of ulipristal acetate on surgical procedures for uterine fibroids in France. BMJ open, 2017, Sep-03, Volume: 7, Issue:9 Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Cost Savings; Databases, Factual; Female; France; Gynecologic Surgical Procedures; Humans; Leiomyoma; Linear Models; Middle Aged; Norpregnadienes; Retrospective Studies; Uterine Neoplasms; Young Adult	2017
Endometrial Changes in Surgical Specimens of Perimenopausal Patients Treated With Ulipristal Acetate for Uterine Leiomyomas. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2018, Volume: 37, Issue:6 Topics: Adult; Endometrium; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Perimenopause; Uterine Neoplasms	2018
Endometrial cancer after ulipristal acetate for uterine fibroma. European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 219 Topics: Endometrial Neoplasms; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Uterine Hemorrhage	2017
Progesterone Receptor Isoforms, Nuclear Corepressor-1 and Steroid Receptor Coactivator-1 and B-Cell Lymphoma 2 and Akt and Akt Phosphorylation Status in Uterine Myomas after Ulipristal Acetate Treatment: A Systematic Immunohistochemical Evaluation. Gynecologic and obstetric investigation, 2018, Volume: 83, Issue:5 Topics: Adult; Case-Control Studies; Co-Repressor Proteins; Female; Humans; Leiomyoma; Norpregnadienes; Nuclear Receptor Coactivator 1; Phosphorylation; Prospective Studies; Protein Isoforms; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Receptors, Progesterone; Uterine Neoplasms	2018
Letter to the Editor/Comments on "Endometrial cancer after ulipristal acetate for uterine fibroma" by Ignatov et al. Eur J Obstet Gynecol Reprod Biol 2017; Dec;219:134. European journal of obstetrics, gynecology, and reproductive biology, 2018, Volume: 223 Topics: Endometrial Neoplasms; Female; Humans; Leiomyoma; Norpregnadienes	2018
Non-surgical intervention for retroperitoneal lymphogenic and pulmonary metastases of a benign leiomyoma: treatment with ulipristal acetate. BMJ case reports, 2018, Jan-03, Volume: 2018 Topics: Adult; Contraceptive Agents, Female; Diagnosis, Differential; Female; Humans; Leiomyoma; Lung; Lung Neoplasms; Norpregnadienes; Omentum; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2018
Outcome of patients with uterine fibroids after 3-month ulipristal acetate therapy. European journal of obstetrics, gynecology, and reproductive biology, 2018, Volume: 222 Topics: Adult; Antineoplastic Agents, Hormonal; Cohort Studies; Contraceptives, Oral, Hormonal; Drug Resistance; Female; France; Hospitals, University; Humans; Leiomyoma; Leiomyomatosis; Magnetic Resonance Imaging; Menorrhagia; Norpregnadienes; Pelvic Pain; Retrospective Studies; Slovenia; Tumor Burden; Ultrasonography; Uterine Neoplasms; Young Adult	2018
Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs. European journal of obstetrics, gynecology, and reproductive biology, 2018, Volume: 222 Topics: Adult; Cohort Studies; Combined Modality Therapy; Contraceptives, Oral, Hormonal; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Hysterectomy; Italy; Leiomyoma; Leiomyomatosis; Models, Economic; Norpregnadienes; Preoperative Care; Quality of Life; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Artery Embolization; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms	2018
Matrix Metalloproteinase Activity Correlates With Uterine Myoma Volume Reduction After Ulipristal Acetate Treatment. The Journal of clinical endocrinology and metabolism, 2018, 04-01, Volume: 103, Issue:4 Topics: Female; Humans; Leiomyoma; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Norpregnadienes; Prospective Studies; Tissue Inhibitor of Metalloproteinase-1; Tumor Burden; Uterine Neoplasms	2018
Influence of Ulipristal Acetate Therapy on Uterine Fibroid-Related Symptoms and on Uterine and Fibroid Volumes and Vascularity Indices Assessed by Ultrasound. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2018, Volume: 37, Issue:9 Topics: Adult; Contraceptive Agents, Female; Female; Humans; Leiomyoma; Longitudinal Studies; Middle Aged; Norpregnadienes; Organ Size; Prospective Studies; Treatment Outcome; Ultrasonography, Doppler; Uterus	2018
Ulipristal acetate decreases transforming growth factor β3 serum and tumor tissue concentrations in patients with uterine fibroids. Fertility and sterility, 2018, Volume: 109, Issue:3 Topics: Adult; Age Factors; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Body Mass Index; Down-Regulation; Female; Hospitals, University; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Retrospective Studies; Time Factors; Transforming Growth Factor beta3; Treatment Outcome; Uterine Neoplasms; Young Adult	2018
Ulipristal acetate for uterine fibroids: 2 years of real world experience in a UK hospital. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2018, Volume: 38, Issue:6 Topics: Adult; Contraceptive Agents, Female; England; Female; Humans; Leiomyoma; Menorrhagia; Middle Aged; Norpregnadienes; Treatment Outcome; Uterine Neoplasms; Young Adult	2018
Predictive factor for volume reduction of uterine fibroids after short-term use of ulipristal acetate. European journal of obstetrics, gynecology, and reproductive biology, 2018, Volume: 224 Topics: Adult; Contraceptive Agents, Female; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Retrospective Studies; Treatment Outcome; Uterine Neoplasms	2018
Gene expression changes in uterine myomas in response to ulipristal acetate treatment. Reproductive biomedicine online, 2018, Volume: 37, Issue:2 Topics: Female; Gene Expression; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Treatment Outcome; Uterine Neoplasms; Uterus	2018
Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve - an observational study. Journal of ovarian research, 2018, Jun-01, Volume: 11, Issue:1 Topics: Adult; Anti-Mullerian Hormone; Female; Follicle Stimulating Hormone; Humans; Hysterectomy, Vaginal; Leiomyoma; Luteinizing Hormone; Norpregnadienes; Ovarian Follicle; Ovarian Reserve; Ovary; Prospective Studies; Uterine Artery Embolization; Uterine Myomectomy	2018
Changes in sexuality during ulipristal acetate treatment in women with symptomatic uterine fibroids. European journal of obstetrics, gynecology, and reproductive biology, 2018, Volume: 228 Topics: Adult; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Sexuality	2018
Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial. Obstetrics and gynecology, 2018, Volume: 132, Issue:1 Topics: Humans; Leiomyoma; Norpregnadienes	2018
In Reply. Obstetrics and gynecology, 2018, Volume: 132, Issue:1 Topics: Humans; Leiomyoma; Norpregnadienes	2018
Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports. Medicine, 2018, Volume: 97, Issue:31 Topics: Diagnosis, Differential; Female; Humans; Leiomyoma; Leiomyosarcoma; Middle Aged; Morcellation; Norpregnadienes; Uterine Myomectomy; Uterine Neoplasms	2018
A-Kinase Anchoring Protein 13 (AKAP13) Augments Progesterone Signaling in Uterine Fibroid Cells. The Journal of clinical endocrinology and metabolism, 2019, 03-01, Volume: 104, Issue:3 Topics: A Kinase Anchor Proteins; Adult; Animals; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Female; Gene Knockdown Techniques; Humans; Leiomyoma; MAP Kinase Signaling System; Mechanotransduction, Cellular; Middle Aged; Minor Histocompatibility Antigens; Norpregnadienes; Progesterone; Proto-Oncogene Proteins; Receptors, Progesterone; RNA, Small Interfering; Uterine Neoplasms; Uterus	2019
[Ulipristal acetate and SPRM: A new entity for the therapeutic strategy for symptomatic myomas]. Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:10-11 Topics: Adult; Female; Humans; Leiomyoma; Norpregnadienes; Receptors, Progesterone; Uterine Neoplasms	2018
Ulipristal acetate (Esmya): restrictions on use. Drug and therapeutics bulletin, 2018, Volume: 56, Issue:11 Topics: Chemical and Drug Induced Liver Injury; Humans; Leiomyoma; Liver Function Tests; Norpregnadienes	2018
Ulipristal acetate therapy increases ultrasound features of adenomyosis: a good treatment given in an erroneous diagnosis of uterine fibroids. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2019, Volume: 35, Issue:3 Topics: Adenomyosis; Diagnostic Errors; Disease Progression; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Ultrasonography; Uterine Neoplasms; Uterus	2019
Ulipristal Acetate Mediates Decreased Proteoglycan Expression Through Regulation of Nuclear Factor of Activated T-Cells (NFAT5). Reproductive sciences (Thousand Oaks, Calif.), 2019, Volume: 26, Issue:2 Topics: Extracellular Matrix; Female; Humans; Leiomyoma; NFATC Transcription Factors; Norpregnadienes; Proteoglycans; Uterine Neoplasms	2019
Pregnancy Outcomes Following Ulipristal Acetate for Uterine Fibroids: A Systematic Review. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2019, Volume: 41, Issue:1 Topics: Female; Humans; Leiomyoma; Norpregnadienes; Pregnancy; Pregnancy Outcome	2019
Author Response: Pregnancy Outcomes Following Ulipristal Acetate for Uterine Fibroids: A Systematic Review. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2019, Volume: 41, Issue:1 Topics: Female; Humans; Leiomyoma; Norpregnadienes; Pregnancy; Pregnancy Outcome	2019
Adverse symptoms during short-term use of ulipristal acetate in women with uterine myomas and/or adenomyosis. The journal of obstetrics and gynaecology research, 2019, Volume: 45, Issue:4 Topics: Adenomyosis; Adult; Contraceptive Agents, Female; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Receptors, Progesterone; Uterine Neoplasms; Young Adult	2019
Pathologic Changes in Uterine Leiomyomas After Extended Treatment With Ulipristal Acetate. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2020, Volume: 39, Issue:2 Topics: Adult; Contraceptive Agents, Hormonal; Female; Humans; Leiomyoma; Myometrium; Norpregnadienes; Uterine Neoplasms	2020
Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2019, Volume: 35, Issue:9 Topics: Adult; Bone Density; Drug Administration Schedule; Female; Humans; Italy; Leiomyoma; Menorrhagia; Middle Aged; Norpregnadienes; Quality of Life; Treatment Outcome; Uterine Neoplasms	2019
Which is the destiny of ulipristal acetate for uterine fibroids? A commentary on the Italian medicines agency (AIFA) pronouncements Recenti progressi in medicina, 2019, Volume: 110, Issue:2 Topics: Chemical and Drug Induced Liver Injury; Contraceptive Agents, Female; Female; Humans; Italy; Leiomyoma; Liver Function Tests; Norpregnadienes; Time Factors; Uterine Neoplasms	2019
Ulipristal acetate decreases active TGF-β3 and its canonical signaling in uterine leiomyoma via two novel mechanisms. Fertility and sterility, 2019, Volume: 111, Issue:4 Topics: Adult; Cells, Cultured; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Leiomyoma; Norpregnadienes; Primary Cell Culture; Signal Transduction; Transforming Growth Factor beta3; Uterine Neoplasms	2019
Absence of predictable long-term molecular effect of ulipristal acetate (UPA) on the endometrium. Reproductive biomedicine online, 2019, Volume: 38, Issue:5 Topics: Adult; Cell Proliferation; Contraceptive Agents, Hormonal; Endometrium; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms; Vascular Endothelial Growth Factor Receptor-2	2019
Disappearance of a myoma after pregnancy in a 38 years old patient, treated by ulipristal acetate without success before getting pregnant. Journal of gynecology obstetrics and human reproduction, 2019, Volume: 48, Issue:9 Topics: Adult; Contraceptive Agents, Hormonal; Female; Humans; Leiomyoma; Magnetic Resonance Imaging; Norpregnadienes; Pregnancy; Remission, Spontaneous; Uterine Neoplasms	2019
Targeting the transforming growth factor-β pathway: a novel mechanism of ulipristal acetate action against uterine fibroids. Fertility and sterility, 2019, Volume: 111, Issue:4 Topics: Humans; Leiomyoma; Norpregnadienes; Transforming Growth Factor beta; Transforming Growth Factor beta3; Transforming Growth Factors	2019
Ulipristal Acetate for Symptomatic Uterine Leiomyomas: Neither the Long-Awaited Panacea, nor the Opening of Pandora's Box. Obstetrics and gynecology, 2019, Volume: 133, Issue:5 Topics: Humans; Leiomyoma; Norpregnadienes; Quality of Life	2019
Ulipristal acetate on quality of life and sexual function of women with uterine fibromatosis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:1 Topics: Activities of Daily Living; Adult; Anxiety; Contraceptive Agents, Hormonal; Depression; Dysmenorrhea; Dyspareunia; Female; Humans; Leiomyoma; Libido; Menorrhagia; Metrorrhagia; Middle Aged; Neoplasms, Multiple Primary; Norpregnadienes; Pelvic Pain; Prospective Studies; Quality of Life; Sexual Dysfunction, Physiological; Sexual Health; Treatment Outcome; Uterine Neoplasms	2020
[Selective progesterone receptor modulators and their therapeutical use]. Ceska gynekologie, 2013, Volume: 78, Issue:2 Topics: Abortion, Induced; Endometriosis; Female; Hormone Antagonists; Humans; Leiomyoma; Mifepristone; Norpregnadienes; Pregnancy; Progesterone; Receptors, Progesterone	2013
The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids. European journal of obstetrics, gynecology, and reproductive biology, 2014, Volume: 175 Topics: Adult; Cost-Benefit Analysis; Female; Humans; Leiomyoma; Models, Economic; Norpregnadienes; Uterine Neoplasms	2014
[Ulipristal acetate (Esmya): a selective modulator of progesterone receptors, new treatment of uterine fibromatosis]. Revue medicale de Liege, 2014, Volume: 69, Issue:4 Topics: Female; Humans; Leiomyoma; Norpregnadienes; Progesterone; Receptors, Progesterone; Uterine Neoplasms	2014
Application of ulipristal acetate in female patients with uterine fibroids. Neuro endocrinology letters, 2014, Volume: 35, Issue:3 Topics: Administration, Oral; Adult; Female; Hormone Antagonists; Humans; Leiomyoma; Menstruation Disturbances; Middle Aged; Norpregnadienes; Receptors, Progesterone; Treatment Outcome; Tumor Burden; Uterine Neoplasms	2014
Ulipristal acetate modulates the expression and functions of activin a in leiomyoma cells. Reproductive sciences (Thousand Oaks, Calif.), 2014, Volume: 21, Issue:9 Topics: Activins; Adult; Female; Gene Expression Regulation, Neoplastic; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Tumor Cells, Cultured; Uterine Neoplasms	2014
Influence of ulipristal acetate therapy compared with uterine artery embolization on fibroid volume and vascularity indices assessed by three-dimensional ultrasound: prospective observational study. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2015, Volume: 45, Issue:6 Topics: Adult; Case-Control Studies; Female; Humans; Imaging, Three-Dimensional; Leiomyoma; Norpregnadienes; Prospective Studies; Treatment Outcome; Ultrasonography; Uterine Artery Embolization; Uterus	2015
Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids. Women's health (London, England), 2014, Volume: 10, Issue:6 Topics: Female; Humans; Leiomyoma; Norpregnadienes; Receptors, Progesterone; Severity of Illness Index; Uterine Neoplasms	2014
Abnormal excessive per vagina (PV) bleeding on Esmya-selective progesterone receptor modulator (SPRM) in a symptomatic patient with uterine fibroid. BMJ case reports, 2015, May-14, Volume: 2015 Topics: Anemia; Contraceptive Agents; Contraindications; Female; Humans; Hysterectomy; Laparoscopy; Leiomyoma; Middle Aged; Norpregnadienes; Severity of Illness Index; Treatment Outcome; Uterine Hemorrhage	2015
Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist. European journal of obstetrics, gynecology, and reproductive biology, 2015, Volume: 191 Topics: Adult; Antineoplastic Agents, Hormonal; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Caspase 3; Cell Proliferation; Combined Modality Therapy; Female; Gene Expression Regulation, Neoplastic; Humans; Leiomyoma; Leuprolide; Middle Aged; Myometrium; Neoplasm Proteins; Norpregnadienes; Proliferating Cell Nuclear Antigen; Receptor, Platelet-Derived Growth Factor alpha; Receptors, LHRH; Receptors, Progesterone; Uterine Neoplasms	2015
Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study. European journal of obstetrics, gynecology, and reproductive biology, 2015, Volume: 192 Topics: Adult; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Attitude of Health Personnel; Contraceptive Agents; Female; Humans; Hysteroscopy; Leiomyoma; Letrozole; Nitriles; Norpregnadienes; Operative Time; Pain, Postoperative; Patient Satisfaction; Pilot Projects; Prospective Studies; Triazoles; Triptorelin Pamoate; Tumor Burden; Uterine Neoplasms	2015
Pseudo-Meig's Syndrome in a Woman on Ulipristal Acetate. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2015, Volume: 37, Issue:6 Topics: Adult; Female; Humans; Leiomyoma; Meigs Syndrome; Norpregnadienes; Uterine Neoplasms	2015
Spontaneous Pregnancy Following Ulipristal Acetate Treatment in a Woman with a Symptomatic Uterine Fibroid. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2016, Volume: 38, Issue:1 Topics: Abortion, Habitual; Adult; Contraceptive Agents; Delivery, Obstetric; Female; Fertilization; Humans; Leiomyoma; Norpregnadienes; Pregnancy; Pregnancy Outcome; Uterine Neoplasms	2016
Use of Ulipristal Acetate for the Management of Fibroid-Related Acute Abnormal Uterine Bleeding. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2016, Volume: 38, Issue:1 Topics: Adult; Blood Transfusion; Contraceptive Agents; Female; Humans; Laparoscopy; Leiomyoma; Norpregnadienes; Severity of Illness Index; Treatment Outcome; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms	2016
Ulipristal acetate prior to in vitro fertilization in a female patient affected by uterine fibroids: a case report. European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:2 Topics: Adult; Biopsy; Endometrium; Female; Fertilization in Vitro; Fibroma; Humans; Infertility, Female; Leiomyoma; Norpregnadienes; Uterine Hemorrhage; Uterine Neoplasms	2016
Long-term nonsurgical control with ulipristal acetate of multiple uterine fibroids, enabling pregnancy. American journal of obstetrics and gynecology, 2016, Volume: 214, Issue:6 Topics: Adult; Female; Fertilization in Vitro; Humans; Leiomyoma; Magnetic Resonance Imaging; Norpregnadienes; Pregnancy	2016
Repeated-intermittent use of ulipristal acetate for the management of uterine fibroids: an Italian pharmacoeconomic evaluation. Minerva ginecologica, 2016, Volume: 68, Issue:1 Topics: Cost-Benefit Analysis; Drug Administration Schedule; Economics, Pharmaceutical; Female; Humans; Italy; Leiomyoma; Norpregnadienes; Quality of Life; Randomized Controlled Trials as Topic; Uterine Neoplasms	2016
Myoma migration: an unexpected "effect" with Ulipristal acetate treatment. European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:8 Topics: Female; Humans; Leiomyoma; Myoma; Neoplastic Cells, Circulating; Norpregnadienes; Pregnancy; Uterine Myomectomy; Uterine Neoplasms	2016
[Diagnosis and treatment of uterine myoma]. Orvosi hetilap, 2016, May-22, Volume: 157, Issue:21 Topics: Abortion, Habitual; Defecation; Female; Gonadotropin-Releasing Hormone; Humans; Hysteroscopy; Infertility, Female; Laparoscopy; Laparotomy; Leiomyoma; Norpregnadienes; Pelvic Pain; Precision Medicine; Urination Disorders; Uterine Hemorrhage; Uterine Neoplasms	2016
Can ulipristal acetate be a treatment option for patients with menorrhagia and a history of ischemic cerebrovascular accident? Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2016, Volume: 36, Issue:7 Topics: Anemia, Iron-Deficiency; Brain Ischemia; Contraceptive Agents; Disease Management; Female; Humans; Iron; Leiomyoma; Menorrhagia; Middle Aged; Norpregnadienes; Trace Elements; Treatment Outcome	2016
Role of ethnicity in treating uterine fibroids with ulipristal acetate. Fertility and sterility, 2016, Volume: 106, Issue:5 Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Agents, Hormonal; Black People; Female; Healthcare Disparities; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Ontario; Patient Satisfaction; Prospective Studies; Quality of Life; Surveys and Questionnaires; Time Factors; Treatment Outcome; Uterine Neoplasms; White People; Young Adult	2016
Unexpected Uterine Leiomyosarcoma During Laparoscopic Hysterectomy Treated 6 Months With Ulipristal Acetate and Contained Power Morcellation. Journal of minimally invasive gynecology, 2017, Volume: 24, Issue:2 Topics: Delayed Diagnosis; Denmark; Disease Progression; Female; Humans; Hysterectomy; Intraoperative Period; Laparoscopy; Leiomyoma; Leiomyosarcoma; Lung Neoplasms; Menorrhagia; Middle Aged; Minimally Invasive Surgical Procedures; Morcellation; Norpregnadienes; Uterine Neoplasms	2017
Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis. Journal of medical economics, 2017, Volume: 20, Issue:3 Topics: Adolescent; Adult; Budgets; Cost Control; Double-Blind Method; Female; Health Care Costs; Humans; Leiomyoma; Leuprolide; Middle Aged; Netherlands; Norpregnadienes; Preoperative Care; Young Adult	2017
Medical or surgical management of fibroids? An internet survey of gynecologists' views. Maturitas, 2017, Volume: 95 Topics: Attitude of Health Personnel; Clinical Decision-Making; Female; Fertility Preservation; Health Care Surveys; Humans; Hysterectomy; Internet; Leiomyoma; Norpregnadienes; Pregnancy; Progestins; Uterine Myomectomy; Uterine Neoplasms	2017
Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results. European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 208 Topics: Abdominal Pain; Adult; Cohort Studies; Contraceptive Agents; European Union; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Leiomyomatosis; Middle Aged; Norpregnadienes; Organ Sparing Treatments; Prospective Studies; Quality of Life; Severity of Illness Index; Uterine Diseases; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms	2017
Histomorphological changes in endometriosis in a patient treated with ulipristal: A case report. Pathology, research and practice, 2017, Volume: 213, Issue:1 Topics: Adult; Endometriosis; Endometrium; Female; Humans; Leiomyoma; Norpregnadienes; Uterine Neoplasms	2017
Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium. Human reproduction (Oxford, England), 2017, 03-01, Volume: 32, Issue:3 Topics: Adult; Basic Helix-Loop-Helix Transcription Factors; Cell Proliferation; Contraceptive Agents, Female; Endometrium; Female; Forkhead Box Protein O1; Homeobox A10 Proteins; Homeodomain Proteins; Humans; Insulin-Like Growth Factor Binding Protein 1; Interleukin-15; Leiomyoma; Middle Aged; Norpregnadienes; Receptors, Progesterone; Stromal Cells	2017
Safety after extended repeated use of ulipristal acetate for uterine fibroids. PloS one, 2017, Volume: 12, Issue:3 Topics: Adult; Biopsy; Clinical Trials, Phase III as Topic; Contraceptive Agents; Endometrium; Female; Follow-Up Studies; Humans; Leiomyoma; Middle Aged; Norpregnadienes	2017
Uterine fibroids and evidence-based medicine--not an oxymoron. The New England journal of medicine, 2012, Feb-02, Volume: 366, Issue:5 Topics: Female; Humans; Leiomyoma; Leuprolide; Menorrhagia; Norpregnadienes; Receptors, Progesterone; Uterine Neoplasms	2012
Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment. Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:7 Topics: Adult; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Female; Hormone Antagonists; Humans; Leiomyoma; Menorrhagia; Mifepristone; Norpregnadienes; Progesterone; Receptors, Progesterone; Uterine Neoplasms	2012
Ulipristal acetate does not impact human normal breast tissue. Human reproduction (Oxford, England), 2012, Volume: 27, Issue:9 Topics: Adolescent; Adult; Animals; Apoptosis Regulatory Proteins; Breast; Contraceptive Agents; Cyclin A; Dexamethasone; Epithelial Cells; Estradiol; Fatty Acid Synthase, Type I; Female; Genes, Reporter; Humans; Ki-67 Antigen; Leiomyoma; Mammary Glands, Human; Membrane Proteins; Mice; Mice, Nude; Middle Aged; Norpregnadienes; Progesterone; Proto-Oncogene Proteins c-bcl-2; Receptors, Glucocorticoid; Transcriptional Activation; Transplantation, Heterologous	2012